Novus is a biotechnology company focusing on the R&D and production of biomaterials for use in orthopaedics. In addition to the R&D and production of our core biomaterial products, Novus's consultancy arm - Metis N, provides a wide range of technology consultancy. Most notably, we helped numerous company to build ISO 13485 certified medical device manufacturing plants and P2/3 PCR laboratories for Covid-19. Novus is led by a team of experienced professionals with strong backgrounds in medical and health industry. We have a dozen of in-house PhD scientists with strong backgrounds in chemical engineering, molecular, cancer, nanotechnology, orthopaedics and material sciences. The team is dedicated in bringing values to the field of biotechnology through commercialisation process. Through active participation, Novus is a recognised industry partner in a number of health and medical projects and joint-ventures. As of 2021, Novus is the parent company of the Novus's group of companies with 4 subsidiaries in the field of biotechnology. 2014 Global Entrepreneurship Week Finalist (GEW50) CNBC's 20 of the world hottest start-up in 2014 2015 SME’s Youth Entrepreneur Award, Hong Kong General Chamber of Small and Medium Business (香港中小型企業總商會 - 2015 中小企青年創業獎) 2016 Hong Kong's 20 hottest startups, Hong Kong Business Magazine Asia's Top 100 by Echelon Asia Summit Top 50 and Hong Kong Champion - Innovation Forum IMAGINE IF! Deep Tech Accelerator 2017 Jumpstarter Healthy Aging Winner HKU DreamCatcher 100K Winner French Tech Ticket Awardee 2018 IPIEC Global Champion Top 500 DeepTech Startup Worldwide South-East Asia x HK Top 10 Startup Fosun Challege Day Champion 2019 HKSTP Incu-Bio Graduation www.novusls.com